The abstract is read at the publisher; the summary is JClub's.
International consensus guidance outlines principles and minimum requirements for general population screening for islet autoantibodies to diagnose early-stage type 1 diabetes.
- Why it matters: With rising global incidence and substantial rates of diabetic ketoacidosis at clinical diagnosis, earlier detection could enable prevention of severe onset and better outpatient management.
- What they did: The nominal group technique process produced recommendations on implementing population islet autoantibody screening, including programme prerequisites for effective early-stage diagnosis.
- The result: The guidance supports earlier identification, monitoring, education, timely insulin initiation, and access to disease-modifying therapies that can delay clinical onset.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.
- 1 cited this week
- Open access